AzTrials
AzTrials

Atrial FibrillationNCT00434694

A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation

A study testing Pulmonary Vein Isolation (Radiofrequency Catheter Ablation) in people with Atrial Fibrillation, run by University of Pennsylvania at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a study of different techniques for treatment of atrial fibrillation using a procedure called radiofrequency catheter ablation. Atrial fibrillation (called AF) is when the upper chambers of the heart (the atria) beat much faster than the lower chambers, causing the heart to beat less effectively. Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Atrial Fibrillation
What is being tested?
Pulmonary Vein Isolation (Radiofrequency Catheter Ablation)
Type of treatment
Surgery or procedure
How many people
300 participants
Where
2 sitesUnited States
Study dates
Jul 2003to Feb 2006
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All pts of age 40 years or over that are referred to our center for ablation of AF and meet the clinical criteria to undergo the procedure shall be eligible to participate in the study.

Who cannot join

  • Failure to obtain informed consent
  • Age < 40 years
  • Despite the reported low incidence of pulmonic vein stenosis (0.8%) as a potential complication of PV isolation in pts undergoing AF ablation, in younger pts where it appears that AF results mostly from foci from a limited number of PVs, we feel that including them in the current study with a possibility of having all 4 PVs isolated cannot be justified.

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

  • Presbyterian Medical Center

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Official title: Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation: Efficacy of Isolating All Veins Vs Arrhythmogenic Veins Only Using Standard 4-mm or 8-mm Ablation Catheter Vs Saline Irrigated Cooled Tip Catheter

This is a study of different techniques for treatment of atrial fibrillation using a procedure called radiofrequency catheter ablation. Atrial fibrillation (called AF) is when the upper chambers of the heart (the atria) beat much faster than the lower chambers, causing the heart to beat less effectively. AF can cause stroke, impaired performance, palpitations, shortness of breath, passing out and other symptoms. Radiofrequency ablation involves placement of catheter/electrode wires into the heart through plastic tubes inserted into veins / arteries in both the groins and the right side of the neck under local anesthesia. Radiofrequency energy is delivered to the areas inside the heart that cause the rapid firing of the atria, causing small lesions or "burns" that destroy the heart tissue where the extra electrical impulses come from. Commonly this area is where the four pulmonary veins (PV) deliver blood from the lungs to the left side of the heart, and the procedure is also referred to as "pulmonary vein isolation" or PVI.

This study compares two different strategies for performing the pulmonary vein isolation procedure, and compares the effect using two different types of radiofrequency ablation catheters.

Read the detailed description

Usually there are 4-5 PVs in each person that bring blood form the different lobes of the lung into the LA. Typically the inside lining of the LA extends for 3-7 mm inside the PVs around the entire circumference as they connect (ostium; os) in the form of finger like projections. These projections are thought to be the sites that initiate AF. The procedure involves careful definition of the finger like projections between the LA and PV os using the circular mapping catheter (Lasso). The connections produce specific pattern of electrical recordings which are targeted using the ablation catheter that utilizes radio-frequency energy to create local burns at the point of contact with the inside of the heart. A successful burn destroys these finger-like projections which can be appreciated by loss of the characteristic electrical recordings which were seen pre-ablation. Using this technique, a series of radiofrequency ablation lesions are delivered around the circumference of PV, the end point being obliteration of all electrical recordings between the left atrium and the PV of interest (also called "Electrical Isolation" of PV from the rest of the LA). At this time the ablation procedure for AF involves electrical isolation of either those PVs that have been shown to be the sites from where AF starts (arrhythmogenic PV) or empirically isolating all the PVs that the patient has (typically 4-5). There is lack of data showing benefit of one technique over the other. Additionally, in order to create radiofrequency lesions or burns inside the heart, two different catheter technologies have been approved and are currently in use: 1) radiofrequency delivery using a standard 4-mm tip or 8-mm tip catheter, which creates burns at the point of catheter contact that are approximately 5 mm deep and 2) delivery of radiofrequency energy via saline irrigated cool tip catheter which is capable of creating deeper burns (5 - 10 mm). Once again, for electrical isolation of pulmonic veins in pts with AF, there is no data that proves the benefit of either catheter technology over the other.

PURPOSE AND DURATION: The objectives of the proposed research project are to study:

  • The effectiveness of electrical isolation of only the arrhythmogenic pulmonic veins (PV; partial isolation) vs. electrical isolation empirically of all 4 PV (total isolation) on long-term (1 year) control of Atrial Fibrillation (AF)
  • The effectiveness of a closed loop saline irrigated cooled tip ablation catheter compared with standard 4-mm tip or 8-mm tip ablation catheter in achieving successful electrical isolation of pulmonic vein(s).

Study participants shall have a 1:1 chance of getting either ablation of all 4 PVs vs. only the PVs that are shown to start AF and also for creation of the radiofrequency ablations you have 1:1 chance of being enrolled either in the arm that utilizes the standard catheter vs. that which utilizes the saline irrigated cooled tip catheter. The duration of your participation in the study will be for a maximum of 12 months. This trial is being conducted in approximately 300 patients.

Hypothesis:

Total electrical isolation of all 4 PVs compared with electrical isolation of only PV(s) where abnormal impulses are found should be more efficacious in achieving long-term cure of patients undergoing ablation for AF. Furthermore, the saline irrigated cooled tip catheter should be able to accomplish successful EI of PV(s) in either group with lesser number of lesions when compared with the standard 4-mm tip or 8-mm tip ablation catheter.

Being tested
Pulmonary Vein Isolation (Radiofrequency Catheter Ablation)
Keywords
Atrial Fibrillation, Catheter ablation, Pulmonary Vein
Medical subject headings
Atrial Fibrillation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pulmonary Vein Isolation (Radiofrequency Catheter Ablation)Procedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Long-term control of AF (defined as complete freedom and/or >90% reduction in AF burden) either off or on previously ineffective antiarrhythmic drugs (AAD) at 1 year after a single ablation procedure.

Secondary outcomes (4)
  1. Efficacy of either strategy in achieving freedom from AF off AAD at 1 year after a single ablation procedure

  2. Total procedure time

  3. Total fluoroscopy time

  4. Serious cardiac adverse events, including: cerebrovascular events, pericardial effusion resulting in tamponade, significant PV stenosis, left atrial-esophageal fistula and death.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2007 (estimated)
  2. Study startJul 2003
  3. Primary completionFeb 2006
  4. Study completionFeb 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00434694
Sponsor's protocol ID
Penn:PVI Strategies
Status last verified
Nov 2015
First submitted
12 Feb 2007
Last updated
25 Nov 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Pulmonary Vein Isolation (Radiofrequency Catheter Ablation) in people with Atrial Fibrillation, run by University of Pennsylvania at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Long-term control of AF (defined as complete freedom and/or >90% reduction in AF burden) either off or on previously ineffective antiarrhythmic drugs (AAD) at 1 year after a single ablation procedure.. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2015; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in